CTRI/2020/11/028967尚未招募未知
Seroprevalence of COVID-19 antibodies in patients on disease modifying anti-rheumatic drugs â?? Multicentric study
Kalinga Institute of Medical Sciences KIMS Regional Medical Research Center ICMR Bhubaneswar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Relative of patient being included in the study, preferably staying the same household.
- •2.No known rheumatic diseases
排除标准
- •1.Acquired immunodeficiency syndrome
- •2.Any active infection as indicated by patient being on systemic antibiotics, anti-fungals or anti-mycobacterial chemotherapy
- •3.Pregnancy , chronic renal failure , chronic liver disease, diabetes mellitus
- •4.Any known malignancy or has received chemotherapy in the last six months
- •5.Patients who have received plasma therapy (for COVID-19)
研究者
相似试验
尚未招募
不适用
Seroprevalence of COVID-19 antibodies among patients living with hemophilia.CTRI/2022/06/043017Maulana Azad Medical College
已完成
不适用
Seroprevalence of SARS-CoV-2 antibodies among healthcare workers with differing risk of exposureCOVID-1910047438NL-OMON49447niversitair Medisch Centrum Groningen600
进行中（未招募）
不适用
Prevalence of COVID19 antibodies among blood donors.CTRI/2021/01/030455ivetha M
招募中
不适用
Seroprevalence of anti-SARS-CoV-2 antibody in response to COVID-19 vaccine in patients with i nflammatory bowel diseaseKCT0006901Keimyung University Dongsan Hospital150
招募中
不适用
Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in LeipzigU07.1COVID-19, virus identifiedDRKS00023364Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig2,000